Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food-Effect Study of KH607 Tablets in Healthy Chinese Participants
NCT07634874Phase 1Not yet recruiting
- Sponsor
- Chengdu Kanghong Pharmaceutical Group Co., Ltd.
- Start
- Jun 2026
- Primary completion
- Jul 2026
01
Overview
Phase 1, randomised, open-label trial of KH607 (2 arms), sponsored by Chengdu Kanghong Pharmaceutical Group Co., Ltd. Primary endpoints: Area Under the Curve from Time Zero to Last Quantifiable Concentration at 96 hours, Area Under the Curve from Time Zero to Infinity at 96 hours and 2 more. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
KH607
Beyond the preview
Go deeper on NCT07634874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07634874.